Home · Health · Nov 17 archive
White House Withdraws Overton's FDA Nomination
· Confirmed
In Short: The White House has withdrawn Dr. Heidi Overton's nomination to lead the Food and Drug Administration amid growing opposition from Senate Republicans.

Heidi Overton (Wikidata P18).
Trump's pick Heidi Overton dropped as nominee for FDA commissioner. ABC News
The White House has withdrawn Dr. Heidi Overton's nomination to lead the Food and Drug Administration (FDA) amid growing opposition from Senate Republicans.
Overton, a physician and White House domestic policy adviser, faced bipartisan questions about her willingness to break from President Donald Trump's agenda, particularly on unsupported claims about the dangers of childhood vaccines.
Senate health committee Chairman Bill Cassidy, a Republican from Louisiana, expressed strong concerns about Overton's nomination, citing her lack of managerial experience and her role in efforts to change childhood vaccine guidelines.
Overton stood beside Trump when he signed an executive order calling for changes to childhood vaccine recommendations, including splitting up the combined measles, mumps, and rubella vaccine.
To advance to the full Senate, Overton needed the votes of all 12 Republicans on the Senate Health, Education, Labor and Pensions Committee, a requirement she could not meet.
The White House reportedly pulled Overton's nomination after she faced skepticism from some Republicans over her role in the administration's efforts to change childhood vaccine recommendations.
Overton's confirmation hearing in September was contentious, with senators questioning her ability to go against Trump's agenda.
Some Trump administration officials had grown skeptical that the Senate would confirm Overton, prompting discussions about whether to shore up her nomination or abandon it.
Sen. Roger Marshall (R-KS) has been suggested as a possible replacement for Overton.
Overton's White House record appeared to work against her during the hearing, as many senators noted her support for Trump's plan to break up combination vaccines.
The FDA regulates products that account for about 20% of U.S. Consumer spending, making Overton's nomination a significant political and public health issue.
The White House's decision to withdraw Overton's nomination was described as 'odd' by Cassidy, who had previously called Overton’s support for Trump's vaccine plan 'almost disqualifying.'
What this adds
The decision follows concerns that Overton lacked sufficient support from Republicans on the Senate’s health panel, which had been expected to vote on her nomination Wednesday.
Background
The White House has withdrawn Dr. Heidi Overton's nomination to lead the Food and Drug Administration amid growing opposition from Senate Republicans.
The White House has withdrawn Dr. Heidi Overton's nomination to lead the Food and Drug Administration (FDA) amid growing opposition from Senate Republicans.
What's confirmed
- Republican Sen. Bill Cassidy, who chairs the Senate health committee, said earlier in the day he remained undecided about Overton ahead of a critical vote on her nomination scheduled for Wednesday.
- Overton, a physician and White House domestic policy adviser, has spent most of her professional career working directly for President Donald Trump or conservative groups aligned with his agenda.
- But Overton faced bipartisan questions in the Senate about her willingness to break from Trump, particularly on his unsupported claims about the dangers of childhood vaccines.
- Heidi Overton to lead the Food and Drug Administration amid growing indications she didn’t have the votes needed to win Senate confirmation.
- The White House reportedly pulled its nomination Tuesday for Heidi Overton to lead the Food and Drug Administration over concerns that she would not have the congressional support to get confirmed.
- To win confirmation, Overton would have needed the votes of all 12 Republicans on the Senate Health, Education, Labor and Pensions Committee.
- Without support of the committee, Overton faced little chance of winning a full Senate vote on chamber floor.
- Earlier this month, Calley Means told Joe Rogan that White House aides, including Overton, worked within the administration to advance a Supreme Court decision blocking thousands of lawsuits over the weedkiller glyphosate.
- Sen. Roger Marshall (R-KS) has been suggested as a possible replacement for Overton, Semafor reported on Tuesday.
- Overton was set to face a key vote on Wednesday in the Senate health committee, where the Republicans hold a one-vote majority.
- Overton stood beside Trump when he announced an executive order to reduce and separate the childhood vaccine schedule.
- She called the action “historic,” prompting criticism from Republicans.
What's still developing
- "It is a time to vet nominees and seek commitments before they take office."
- Wade and called for strict restrictions on medication abortion.
- Overton is an outspoken abortion critic and would oversee an ongoing FDA review of mifepristone, the nation's leading abortion pill.
- To become commissioner, Overton will need a majority of votes from the 21-member health committee, followed by a positive vote from the full Senate.
- Republicans hold a slim one seat majority on the committee— for now.
- A vote in Overton’s favor was looking increasingly unlikely, however, as rumblings from certain Senators and media outlets over the past few days made clear.
- Prior to joining the White House, Overton worked as chief policy officer at the conservative think tank America First Policy Institute.
- Republicans have only a narrow window to confirm dozens of Trump administration nominees before Democrats take over Congress next year. (Francis Chung/POLITICO/AP) The White House is dropping Heidi Overton’s nomination for commissioner of the Food and Drug Administration amid pressure campaigns by anti-abortion and anti-vaping advocates, according to a White House spokesperson.
- Overton faced questions from both parties during her confirmation process regarding her positions on vaccines, abortion policy, and the regulation of flavored vaping products.
- Some Trump officials working on Overton’s nomination began to doubt whether she had enough support among Senate Republicans after the party faced sweeping losses in this month’s midterm elections, costing them control of the House of Representatives and the Senate.
- Overton has had an uphill battle since she was first named the nominee to replace Marty Makary, who resigned in May.
Sources
- Biospacelink
- Bozeman Daily Chroniclelink
- Breitbartlink
- CBS Newslink
- Fox Newslink
- Justthenewslink
- Komonewslink
- MS NOWlink
- Medicaleconomicslink
- NBC Newslink
- NTD Newslink
- Ritzheraldlink
- STATlink
- WJARlink
- WLWTlink
- WTOP Newslink
- NBC News — video link
- ABC News — video link
- CBS Detroit — video link
- The Harold — video link
- Unspinly — video link
- WUSA9 — video link
